From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow
BioProcessing Journal · 28.07.2026 · 3
DOI: 10.12665/j152.carson ↗Kurz gefasst
Fachartikel in der Zeitschrift BioProcessing Journal, online erschienen am 28.07.2026. Verfasst von Keith L. Carson.
Abstract (Originalsprache)
As biologics continue to advance at a dizzying pace, I want to take this opportunity to outline what I see as the major successes, as well as the primary challenges facing the industry. First, the science of antibody production appears to be quite settled. Significant value can be gained by finding ways to limit production batches to volumes that can be accommodated by single-use bioreactor systems...
Zitieren
APA
Carson, K. L. (2026). From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow. BioProcessing Journal, 3. https://doi.org/10.12665/j152.carson
Vancouver
Carson KL. From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow. BioProcessing Journal. 2026:3. doi:10.12665/j152.carson
BibTeX
@article{Carson2026,
author = {Carson, Keith L.},
title = {From the Editor-in-Chief: Major Successes in the Industry and Primary Challenges That Follow},
journal = {BioProcessing Journal},
year = {2026},
pages = {3},
doi = {10.12665/j152.carson}
}
EUVIMED